RxDoctor Payments Data

William Levine, MD

Orthopaedic Surgery · New York, NYNPI 1467493478

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $815,596 of the $1,104,639 with a category attached, or 73.8%. Zimmer Biomet accounts for 97.4% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $458,875, more than ten times the $2,845 reported in 2019. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,104,639in general payments, 2019–2025

Across 263 payments — averaging $4200.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$1.1M
  • Medical Device Business Services, Inc.$22K
  • Gotham Surgical Solutions & Devices, Inc.$2K
  • Depuy Synthes Products, Inc.$2K
  • Smith+Nephew$686
  • Stryker$641
  • plus $1K from 9 others
$74,318in research payments, 2019–2025

Across 8 payments — averaging $9289.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$63K
  • Stryker$11K

What the payments were for

  • Royalty or licence$815,59674%
  • Consulting fees$83,4358%
  • Travel & lodging$15,2841%
  • Food & beverage$7,8061%
  • Education$182,47117%
  • Entertainment$480%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,104,639 in reported general payments places this provider in the 95th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$294,788
Medicare patients
478
Services billed
961

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naproxen99$756
Meloxicam11$36
Amoxicillin11$18

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →